期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Development and clinical advancement of small molecules for ex vivo expansion of hematopoietic stem cell
1
作者 Jiaxing Li Xiao Wang +6 位作者 Jiayu Ding yasheng zhu Wenjian Min Wenbing Kuang Kai Yuan Chengliang Sun Peng Yang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第6期2808-2831,共24页
Hematopoietic stem cell(HSC) transplantation is the only curative therapy for many diseases.HSCs from umbilical cord blood(UCB) source have many advantages over from bone marrow.However,limited HSC dose in a single CB... Hematopoietic stem cell(HSC) transplantation is the only curative therapy for many diseases.HSCs from umbilical cord blood(UCB) source have many advantages over from bone marrow.However,limited HSC dose in a single CB unit restrict its widespread use.Over the past two decades,ex vivo HSC expansion with small molecules has been an effective approach for obtaining adequate HSCs.Till now,several small-molecule compounds have entered the phase Ⅰ/Ⅱ trials,showing safe and favorable pharmacological profiles.As HSC expansion has become a hot topic over recent years,many newly identified small molecules along with novel biological mechanisms for HSC expansion would help solve this challenging issue.Here,we will give an overview of HSC biology,discovery and medicinal chemistry development of small molecules,natural products targeting for HSC expansion,and their recent clinical progresses,as well as potential protein targets for HSC expansion. 展开更多
关键词 HSC Small molecule EXPANSION CLINICAL TARGETS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部